ATH 0.00% 0.3¢ alterity therapeutics limited

phase 2b/3 funding., page-3

  1. 597 Posts.
    "They have a massive amount of scientific/clinical data supporting their hypothesis and are churning out papers at an pretty astonishing rate."


    Gotta show something for the big house, shiny car and private schooling.

    Fact is, pharma know all about this drug and this company. Tha nobody has done anything about it is testament to the fact that nobody wants it. Three month stats are nothing. Just way too short.

    The message from pharma is, fund a decent trial yourself with the money you don't have, or let us partner you for nickels and dimes.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $17.43K 5.81M

Buyers (Bids)

No. Vol. Price($)
74 107941696 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 1179951 2
View Market Depth
Last trade - 15.31pm 07/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.